跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 126,266 条关于
“rare blood cancers”
全部
126,266
临床试验
104,984
药物
1,861
机构
659
资讯
18,762
上个月
CAR T Cell Therapy Targets CALR Mutation Driving Rare Blood Cancers
去年
Wugen Initiates Pivotal Trial of Novel Off-the-Shelf CAR-T Therapy for Rare Blood Cancers
9个月前
AOP Health Presents New Clinical Data for Ropeginterferon Alfa-2b in Rare Blood Cancers at ASH 2025
2个月前
Landmark NHS Approval of Dabrafenib and Brentuximab-Vedotin Combination Offers New Hope for Patients with Rare Blood Cancers
去年
Servier India Launches First-in-Class IDH1-Targeted Therapy Ivosidenib for Rare Blood and Bile Duct Cancers
10个月前
Galecto Completes $285M Acquisition of Damora Therapeutics to Advance Rare Blood Cancer Pipeline
2年前
MAIA Biotechnology's Shares Surge Following FDA Approval of Telomerase Inhibitor
去年
Takeda Partners with Asian Hospital to Expand Access to Rare Disease Treatments in Philippines
去年
FDA Rejects Atara Biotherapeutics' Blood Cancer Treatment, Shares Plunge
上个月
First-in-Class ADAR1 Inhibitor Rebecsinib Enters Phase 1 Trial for AML and Myelofibrosis at UC San Diego
第 1 页,共 1877 页
上一页
下一页